UNSPSC 85812727: Introduction of oxazolidinones into upper gi, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of oxazolidinones into upper gi, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0G728

UNSPSC 85812727 Introduction of oxazolidinones into upper GI, via natural or artificial opening is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code's nominal scope—pharmaceutical administration procedures—does not match the work being solicited under it in practice. Recent opportunities tagged to this code span virtual urgent care services, occupational health screening, cancer registry operations, retinal imaging device services, EMS staffing, employee wellness programs, and behavioral health crisis interventions—none of which constitute procedural pharmaceutical administration. Inland Empire Health Plan (IEHP) in California posted an RFI on October 16, 2026 (due October 31) for 24/7/365 virtual urgent care with physician authority to prescribe, and the Nevada Health Authority issued two RFPs in October 2026 for statewide Program of All Inclusive Care for the Elderly (PACE) operations and a Rural Value Acceleration Network (RVAN) vendor role—neither directly procedural in nature. The mismatch between the code's technical description and the actual scope of work solicited suggests either systematic miscoding at the issuing-body level or that this particular commodity code does not represent a meaningful procurement category for state and local government purchasers today.

The geographic distribution of tagged opportunities spans California (Inland Empire Health Plan and San Mateo County), Nevada (statewide), Colorado (Boulder County and Denver), Georgia (DeKalb County and Forsyth County), and scattered activity in Florida, Illinois, Kansas, Oregon, Arizona, and elsewhere across the country. No single jurisdiction or state dominates the recent activity. Given the lack of coherent procedural pharmaceutical solicitations under this code and the absence of repeat buyers pursuing oxazolidinone-administration services, the code does not represent actionable procurement opportunity for vendors in the pharmaceutical procedure, healthcare staffing, or related sectors at this time.